Search companies or stocks...
CABACabaletta Bio, Inc.
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated…
Current stock price of Cabaletta Bio, Inc. (CABA) stock is $3.570. The stock price is +8.18% higher in the session. The intraday range can be seen from this page. Volume of Cabaletta Bio, Inc. (CABA) stock is 8.03M.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of Cabaletta Bio, Inc. (CABA) can change with earnings, company news, and overall market sentiment. Cabaletta Bio, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Cabaletta Bio, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CABA on this page is -2.27. EPS on this page is -1.57. Compare those figures with peers and growth expectations before deciding if the current Cabaletta Bio, Inc. price is justified.
Historical performance for Cabaletta Bio, Inc. (CABA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CABA reacted to past earnings and market events.
Buying Cabaletta Bio, Inc. (CABA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
